From September 19 to 23, 2018, the 21st National Conference on Clinical Oncology and the 2018 CSCO Annual Conference kicked off at the Xiamen International Convention and Exhibition Center, with the theme of "Promoting Clinical Research and Writing a New Chapter in Anti-cancer Treatment". 30,000 participants from all over the country, including more than 800 speakers and paper presenters from home and abroad, gathered in Xiamen to participate in the grand event. This is an exchange event for Asian clinical oncologists to discuss and exchange experience, an academic event for global oncologists to gather and explain the cutting-edge knowledge of cancer diagnosis and treatment, and a brilliant event to show the research results and development trends of clinical oncology in China!

From September 19 to 23, 2018, the 21st National Conference on Clinical Oncology and the 2018 CSCO Annual Conference kicked off at the Xiamen International Convention and Exhibition Center, with the theme of "Promoting Clinical Research and Writing a New Chapter in Anti-cancer Treatment". 30,000 participants from all over the country, including more than 800 speakers and paper presenters from home and abroad, gathered in Xiamen to participate in the grand event. This is an exchange event for Asian clinical oncologists to discuss and exchange experience, an academic event for global oncologists to gather and explain the cutting-edge knowledge of cancer diagnosis and treatment, and a brilliant event to show the research results and development trends of clinical oncology in China!

There was a steady stream of visiting doctors at the booth, and the crowds were crowded. The company's flagship product "Shengbai Oral Liquid (Mixture)" has also won unanimous praise from many doctors and experts.

In September 2018, the largest and highest level academic event in the field of clinical oncology in China witnessed the take-off of Mengyang Pharmaceutical Co., Ltd., and played a very good role in the promotion of enterprises and products. It not only enhances the brand image, enhances the company's popularity and influence in the industry, but also rave reviews and attracts attention for its fist product, Shengbai Oral Liquid (Mixture), which in turn boosts the development and expansion of the national market of the product.

No matter in the past, present or future, Mengyang Pharmaceutical will definitely conform to the trend of the times, shoulder the responsibility of the times, actively respond to the call of the country, continuously promote the national strategy of "Healthy China", fully communicate with people in the same way, and work together to improve the level of clinical diagnosis and treatment of tumors!